{
    "id": 25942,
    "fullName": "RAD51 dec exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "RAD51 dec exp indicates decreased expression of the Rad51 protein and/or mRNA. However, the mechanism causing the decreased expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 5888,
        "geneSymbol": "RAD51",
        "terms": [
            "RAD51",
            "BRCC5",
            "FANCR",
            "HRAD51",
            "HsRad51",
            "HsT16930",
            "MRMV2",
            "RAD51A",
            "RECA"
        ]
    },
    "variant": "dec exp",
    "createDate": "01/18/2017",
    "updateDate": "05/15/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 9774,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, knockdown of RAD51 in a BRCA1 mutant TNBC cell line demonstrated increased sensitivity to Lynparza (olaparib), resulting in decreased cell viability in culture and reduced tumor growth in cell line xenograft models (PMID: 28034904).",
            "molecularProfile": {
                "id": 27077,
                "profileName": "BRCA1 mut RAD51 dec exp"
            },
            "therapy": {
                "id": 837,
                "therapyName": "Olaparib",
                "synonyms": null
            },
            "indication": {
                "id": 60081,
                "name": "triple-receptor negative breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 7596,
                    "pubMedId": 28034904,
                    "title": "RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28034904"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 9779,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, knockdown of RAD51 in a BRCA1 wild-type TNBC cell line demonstrated increased sensitivity to Lynparza (olaparib), resulting in decreased cell viability by 60% in culture and delayed tumor progression in cell line xenograft models (PMID: 28034904).",
            "molecularProfile": {
                "id": 27090,
                "profileName": "BRCA1 wild-type RAD51 dec exp"
            },
            "therapy": {
                "id": 837,
                "therapyName": "Olaparib",
                "synonyms": null
            },
            "indication": {
                "id": 60081,
                "name": "triple-receptor negative breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 7596,
                    "pubMedId": 28034904,
                    "title": "RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28034904"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27076,
            "profileName": "RAD51 dec exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 27077,
            "profileName": "BRCA1 mut RAD51 dec exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 27090,
            "profileName": "BRCA1 wild-type RAD51 dec exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}